The Trend of Eradication Rates of First- and Second-Line Therapy for Helicobacter pylori Infection: Single Center Experience for Recent Eleven Years

被引：0
|
作者：
Yoon, Jai Hoon
Baik, Gwang Ho
Kim, Dae Yong
Kim, Yeon Soo
Suk, Ki Tae
Kim, Jin Bong
Kim, Dong Joon
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S478 / S478
页数：1
相关论文
共 50 条
  • [31] Comparison of 7-and 14-Day Eradication Therapy for Helicobacter pylori with First- and Second-Line Regimen: Randomized Clinical Trial
    Kim, Tae Ho
    Park, Jae Myung
    Cheung, Dae Young
    Oh, Jung Hwan
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (05)
  • [32] Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection
    Tursi, A
    Brandimarte, G
    Giorgetti, G
    Modeo, ME
    Gigliobianco, A
    HEPATO-GASTROENTEROLOGY, 2002, 49 (46) : 1006 - 1009
  • [33] Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection
    Chen, P. -Y.
    Wu, M. -S.
    Chen, C. -Y.
    Bair, M. -J.
    Chou, C. -K.
    Lin, J. -T.
    Liou, J. -M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (05) : 427 - 437
  • [34] COMPARISON WITH ERADICATION RATES OF MOXIFLOXACIN CONTAINING TRIPLE THERAPY AS SECOND LINE TREATMENT FOR HELICOBACTER PYLORI INFECTION ACCORDING TO FIRST LINE REGIMEN
    Kang, K.
    Lee, D.
    Oh, D.
    Kim, N.
    Park, Y.
    Shin, C.
    Yoon, H.
    Jung, H.
    HELICOBACTER, 2013, 18 : 134 - 134
  • [35] Comparison of the efficacy of vonoprazan-based first-line and second-line eradication therapy for Helicobacter pylori infection between 2015 and 2018
    NakagaWa, S.
    Shimoyama, T.
    Onodera, W.
    Chinda, D.
    Iino, C.
    Fukuda, S.
    HELICOBACTER, 2019, 24
  • [36] Second-Line Bismuth-Containing Quadruple Therapy for Helicobacter pylori Infection: A 12-Year Study of Annual Eradication Rates
    Shin, Kiwon
    Cho, Min-Jae
    Oh, Jung-Hwan
    Lim, Chul-Hyun
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (15)
  • [37] RECENT ERADICATION RATE OF RESCUE QUADRUPLE THERAPY AS SECOND-LINE FOR HELICOBACTER PYLORI IN KOREA: A RANDOMIZED RETROSPECTIVE STUDY
    Lee, S.
    Lim, J.
    Lee, D.
    Seol, S.
    Kim, N.
    Park, Y.
    Shin, C.
    Cho, H.
    HELICOBACTER, 2012, 17 : 118 - 118
  • [38] Quadruple therapy should be second-line treatment for Helicobacter pylori infection
    Axon, A
    HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, 2000, : 631 - 635
  • [39] Current status of the first and second line therapy for Helicobacter pylori infection in symptomatic children: A single center study
    Hurduc, V.
    Bordei, L.
    Gales, L.
    Plesca, D.
    HELICOBACTER, 2017, 22
  • [40] The Eradication Efficacies of Hybrid Therapy As First-Line Regimen Plus Levofloxacin-Containing Triple Therapy As Second-Line Regimen for Helicobacter pylori Infection
    Song, Zhiqiang
    Zhou, Liya
    Zhang, Jianzhong
    He, Lihua
    GASTROENTEROLOGY, 2015, 148 (04) : S421 - S421
12345